{"id":"W2959096163","doi":"10.1001/jamaoncol.2019.1588","title":"Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma","year":2019,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":765,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; AstraZeneca","keywords":"Durvalumab; Medicine; Tremelimumab; Gemcitabine; Internal medicine; Population; Combination therapy; Oncology; Surgery; Cancer; Immunotherapy; Ipilimumab; Nivolumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007303766,0.000314203,0.0009330782,0.0001722365,0.0002050821,0.0005233343,0.0002730833,0.0003773401,0.002045451],"category_scores_gemma":[0.000833218,0.0001976833,0.0006668358,0.0002046577,0.0002708361,0.0005695305,0.0001972129,0.0009898301,0.0002883839],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004875884,"about_ca_system_score_gemma":0.0009358547,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003273498,"about_ca_topic_score_gemma":0.001779917,"domain_scores_codex":[0.9997347,0.0001173087,0.00002608689,0.00004720867,0.0000351402,0.00003953432],"domain_scores_gemma":[0.9997039,0.00006876717,0.00008056867,0.00002065245,0.0000172373,0.0001087323],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.524036,0.01937355,0.05068102,0.001687352,0.002876184,0.0007458244,0.0002274165,0.002763053,0.04381258,0.0004511033,0.005074808,0.3482711],"study_design_scores_gemma":[0.3863547,0.4727149,0.09353223,0.0002122122,0.003138951,0.001995399,0.0002042924,0.005403046,0.01679763,0.0005596327,0.01903709,0.00004986635],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922131,0.004770249,0.0002469216,0.0004130106,0.00009188501,0.0003434077,0.0002194041,0.00003295351,0.001669051],"genre_scores_gemma":[0.9970192,0.00124696,0.0005038907,0.0002383168,0.00006733737,0.000170848,0.0001540504,0.00000395704,0.0005955122],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002045451,"threshold_uncertainty_score":0.006842732,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03113434771125084,"score_gpt":0.3374684671745833,"score_spread":0.3063341194633324,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}